Prospective analysis of neutralising antibody titres in secondary non-responders under continuous treatment with a botulinumtoxin type A preparation free of complexing proteins—a single cohort 4-year follow-up study

OBJECTIVES: In long-term botulinum neurotoxin treatment, loss of therapeutic efficacy may occur due to neutralising antibody formation. Preliminary results with incobotulinumtoxinA, a preparation free of complexing/accessory proteins, have indicated a low antigenicity. We hypothesised that continuou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefter, Harald, Hartmann, Christian, Kahlen, Ulrike, Moll, Marek, Bigalke, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449271/
https://www.ncbi.nlm.nih.gov/pubmed/22864418
http://dx.doi.org/10.1136/bmjopen-2011-000646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449271/
https://www.ncbi.nlm.nih.gov/pubmed/22864418
http://dx.doi.org/10.1136/bmjopen-2011-000646

Ejemplares similares